Grange Capital LLC Has $227,000 Stock Holdings in UnitedHealth Group Incorporated $UNH

Grange Capital LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 42.9% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 727 shares of the healthcare conglomerate’s stock after selling 547 shares during the quarter. Grange Capital LLC’s holdings in UnitedHealth Group were worth $227,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of the business. Caitlin John LLC grew its position in shares of UnitedHealth Group by 14.8% during the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after purchasing an additional 111 shares in the last quarter. Murphy Pohlad Asset Management LLC increased its stake in UnitedHealth Group by 21.8% during the 2nd quarter. Murphy Pohlad Asset Management LLC now owns 4,425 shares of the healthcare conglomerate’s stock worth $1,380,000 after acquiring an additional 791 shares during the period. Triumph Capital Management bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $1,324,000. Wealth Effects LLC increased its position in shares of UnitedHealth Group by 14.4% in the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock worth $1,463,000 after purchasing an additional 591 shares during the period. Finally, Towercrest Capital Management acquired a new stake in UnitedHealth Group during the second quarter worth about $236,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 0.8%

Shares of NYSE:UNH opened at $324.29 on Monday. The business has a fifty day simple moving average of $345.84 and a 200 day simple moving average of $321.90. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The firm has a market cap of $293.75 billion, a P/E ratio of 16.93, a P/E/G ratio of 2.28 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same quarter in the prior year, the firm posted $7.15 earnings per share. The business’s quarterly revenue was up 12.2% on a year-over-year basis. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on UNH shares. KeyCorp upped their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Wells Fargo & Company raised their target price on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. JPMorgan Chase & Co. raised their price objective on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Cantor Fitzgerald reissued an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, Sanford C. Bernstein raised their target price on shares of UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Eighteen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.